Cubist Pharmaceuticals News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

16.09.13	Pre-Market Analysis: Amarin Corp. PLC, Elan Corp. PLC, Cubist Pharmaceuticals Inc., and Seattle Genetics Inc. (PR Newswire)
16.09.13	Long-term Agreements, New Launches, Acquisitions and Strategic Collaborations in Improving Medical Research - Research Report Thermo Fisher, Cubist, Agilent, Life Technologies, and Covance (PR Newswire)
16.09.13	Long-term Agreements, New Launches, Acquisitions and Strategic Collaborations in Improving Medical Research - Research Report Thermo Fisher, Cubist, Agilent, Life Technologies, and Covance (PR Newswire)
13.09.13	Cubist Pharma-Optimer Pharma Merger Deal Receives U.S. Antitrust Approval (RTTNews)
11.09.13	Cubist Pharma Completes Acquisition Of Trius Therapeutics Inc. - Quick Facts (RTTNews)
02.09.13	Acquisitions, NDA Filings, Key Findings, Conferences and Product Launches - Research Report on Perrigo, Forest Labs, Avanir Pharmaceuticals, Cubist Pharmaceuticals, and Dr. Reddy's Laboratories (PR Newswire)
08.08.13	Today's Research: Elan Corp. PLC, Amarin Corp. PLC, Seattle Genetics Inc., and Cubist Pharmaceuticals Inc. (PR Newswire)
05.08.13	Acquisitions, R&D Progress, and Financial Results - Research Report on Allergan, Cubist, CHS, Charles River Laboratories, and Cynosure (PR Newswire)
31.07.13	AEGR Nearing $100, ALXA Grows Richer, CBST's Deal Day, BEAT Hits Right Notes (RTTNews)
31.07.13	Cubist Pharma To Buy Trius Therapeutics, Optimer For Up To $1.62 Bln (RTTNews)
31.07.13	After-market Movers For July 30 (SYMC, AMGN, TTWO, CBST, QCOR, RVBD, JIVE, BGFV) (RTTNews)
30.07.13	Cubist To Buy Trius Therapeutics And Optimer Pharmaceuticals - Quick Facts (RTTNews)
23.07.13	Drug Approvals, Study Results, and Clinical Collaborations for Top-Line Growth - Research Report on Pfizer, Merck & Co., Cubist, AstraZeneca and Impax (PR Newswire)
22.07.13	Heptares Achieves First Research Milestone in Research Collaboration with Cubist (PR Newswire)
22.07.13	Heptares Achieves First Research Milestone in Research Collaboration with Cubist (PR Newswire)
18.07.13	Cubist Pharma Q2 Profit Decreases - Quick Facts (RTTNews)
24.10.11	Adolor nach Übernahmeofferte von Cubist im Höhenflug (Aktiencheck)
15.03.10	Cubist Pharmaceuticals President and CEO Michael Bonney Honored by Massachusetts Biotechnology Council with its 2010 Innovative Leadership Award (Businesswire)
08.06.09	Alnylam and Cubist Report Preliminary Data from Phase II Study of ALN-RSV01 in Lung Transplant Patients Naturally Infected with Respiratory Syncytial Virus (Businesswire)
02.06.09	Cubist Pharmaceuticals to Present at June 2009 Investor Conferences (Businesswire)
02.10.08	Cubist Pharmaceuticals to Announce Third Quarter 2008 Financial Results on Thursday, October 16, 2008 (Businesswire)
24.03.08	Tamara Joseph to Succeed Christopher Guiffre as Cubist Pharmaceuticals' General Counsel (Businesswire)
01.08.07	CUBICIN Approved for S. aureus Bloodstream Infections in South Korea and Taiwan (Businesswire)
27.04.05	Cubist Pharmaceuticals to Present at Morgan Stanley Healthcare Confere (Businesswire)
04.04.05	Cubist Pharmaceuticals to Announce First Quarter 2005 Financial Result (Businesswire)
09.03.05	Cubist Pharmaceuticals Names Michael Wood, M.D., and Martin Rosenberg, (Businesswire)
03.03.05	Cubist Pharmaceuticals to Purchase 2% Reduction in CUBICIN Royalty Rat (Businesswire)
21.02.05	Cubist Pharmaceuticals to Present at JMP Securities Fourth Annual Rese (Businesswire)
03.01.05	Cubist Pharmaceuticals to Announce Fourth Quarter 2004 Earnings on Jan (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Logitech Intl	71.14	1.54 %	K V
UBS Group	28.08	1.48 %	K V
Swiss Re	130.05	1.05 %	K V
Part Grp Hldg	1’266.00	0.96 %	K V
ABB	49.48	0.94 %	K V
Geberit	525.20	0.27 %	K V
Alcon	78.04	0.05 %	K V
Givaudan	3’868.00	-0.31 %	K V
CieFinRichemont	121.20	-0.57 %	K V
Sonova Hldg	301.00	-0.99 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Cubist Pharmaceuticals Inc.

Aktien Top/Flop

Cubist Pharmaceuticals Peer Group Nachrichten

Meistgelesene Nachrichten